Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2009

Mar 3, 2009

29777_dirs_2009-03-02_f4cf984e-6fd2-4693-9bb2-d993fcda974b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-02-26

Reporting Person: MAZZO JAMES V (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-02-26 Common shares without par value A 20000 Acquired 20000 Direct
2008-02-26 Common shares without par value A 30000 Acquired 50000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-02-26 Option (right to buy) $21.92 A 98470 Acquired 2012-07-29 Common Shares (98470) Direct
2009-02-26 Option (right to buy) $33.76 A 49235 Acquired 2013-04-29 Common Shares (49235) Direct
2009-02-26 Option (right to buy) $82.19 A 82058 Acquired 2014-05-20 Common Shares (82058) Direct
2009-02-26 Option (right to buy) $93.11 A 75904 Acquired 2015-05-26 Common Shares (75904) Direct
2009-02-26 Option (right to buy) $55.92 A 133838 Acquired 2018-05-29 Common Shares (133838) Direct

Footnotes

F1: These shares represent non-performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program subject to an 18-month cliff vesting period.

F2: These shares represent non-performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year and include the right to have stock withheld for tax purposes.

F3: Fully vested employee stock option received pursuant to the Agreement and Plan of Merger, dated January 11, 2009, by and among Abbott Laboratories, Rainforest Acquisition Inc. and Advanced Medical Optics, Inc. (the "Merger Agreement") in exchange for an employee stock option to acquire 240,000 shares of Advanced Medical Optics, Inc. common stock for $8.99 per share.

F4: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 120,000 shares of Advanced Medical Optics, Inc. common stock for $13.85 per share.

F5: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 200,000 shares of Advanced Medical Optics, Inc. common stock for $33.72 per share.

F6: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 185,000 shares of Advanced Medical Optics, Inc. common stock for $38.20 per share.

F7: Fully vested employee stock option received pursuant to the Merger Agreement in exchange for an employee stock option to acquire 326,200 shares of Advanced Medical Optics, Inc. common stock for $22.94 per share.